Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FFBV0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,582
Award facts
- Contract value 100% obligated
- $16,581.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $16,581.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 150 mg/ml Xolair syringes. The delivery order, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, indicating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its facility in Park Ridge, Illinois, and no subcontractors have been identified for this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy established to provide comprehensive pharmaceutical support to Department of Defense healthcare operations worldwide. The parent contract, awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables. Xolair, an immunosuppressant biologic agent, represents one of the specialized pharmaceutical products within the vendor's extensive portfolio supporting military medical supply needs globally.
Quick answers
Who was awarded contract SPE2DR26FFBV0?
SPE2DR26FFBV0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FFBV0 worth?
The government has obligated $16,582 on SPE2DR26FFBV0.
Is contract SPE2DR26FFBV0 an order under another contract?
Yes. SPE2DR26FFBV0 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBV0 competed?
The extent of competition for SPE2DR26FFBV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award